Omeprazole: a possible new candidate influ... [J Am Coll Cardiol. 2008] - PubMed

Save items

loading

Related citations in PubMed

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. [J Am Coll Cardiol. 2008]
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
Gilard M, Arnaud B, Cornily JC, Le Gal G, Lacut K, Le Calvez G, Mansourati J, Mottier D, Abgrall JF, Boschat J. J Am Coll Cardiol. 2008 Jan 22; 51(3):256-60.
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. [Thromb Haemost. 2009]
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
Sibbing D, Morath T, Stegherr J, Braun S, Vogt W, Hadamitzky M, Schömig A, Kastrati A, von Beckerath N. Thromb Haemost. 2009 Apr; 101(4):714-9.
Clopidogrel and proton pump inhibitors: gastric protection at expense of vascular benefit? [Thromb Haemost. 2009]
Clopidogrel and proton pump inhibitors: gastric protection at expense of vascular benefit?
Serebruany V, Goto S. Thromb Haemost. 2009 Apr; 101(4):607-9.
Review Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians. [J Cardiovasc Pharmacol Ther. 2...]
Review Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
Tran M, Tafreshi J, Pai RG. J Cardiovasc Pharmacol Ther. 2010 Dec; 15(4):326-37. Epub 2010 Oct 11.
Review [Dilemma between gastroprotection and cardiovascular prevention]. [Dtsch Med Wochenschr. 2010]
Review [Dilemma between gastroprotection and cardiovascular prevention].
Venerito M, Kandulski A, Malfertheiner P. Dtsch Med Wochenschr. 2010 Nov; 135(44):2193-8. Epub 2010 Oct 26.

See reviews... See all...

Cited by 1 PubMed Central article

Review Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview. [Vasc Health Risk Manag. 2011]
Review Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview.
Hillegass WB, Brott BC, Dobbs JC, Papapietro SE, Misra VK, Zoghbi GJ. Vasc Health Risk Manag. 2011; 7:445-59. Epub 2011 Jul 18.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Omeprazole: a possible new candidate influencing the antiplatelet effect of clop...
Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel.
J Am Coll Cardiol. 2008 Jan 22 ;51(3):261-3.

PubMed
Dietary strategies for improving post-prandial glucose, lipids, inflammation, an...
Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health.
J Am Coll Cardiol. 2008 Jan 22 ;51(3):249-55.

PubMed
Computer-assisted bar-coding system significantly reduces clinical laboratory sp...
Computer-assisted bar-coding system significantly reduces clinical laboratory specimen identification errors in a pediatric oncology hospital.
J Pediatr. 2008 Feb ;152(2):219-24. Epub 2007 Oct 25 .

PubMed
Transcript-specific translational regulation in the unfolded protein response of...
Transcript-specific translational regulation in the unfolded protein response of Saccharomyces cerevisiae.
FEBS Lett. 2008 Feb 20 ;582(4):503-9. Epub 2008 Jan 17 .

PubMed
The pathogenesis and treatment of no-reflow occurring during percutaneous corona...
The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention.
Cardiovasc Revasc Med. 2008 Jan-Mar ;9(1):56-61.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information